e-learning
resources
Madrid 2019
Saturday, 28.09.2019
PG10 Severe asthma in adults: systematic assessment and biological treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Making clinical sense of the explosion in biologics - which drug for which patient and why?
V. Backer (Copenhagen, Denmark)
Source:
International Congress 2019 – PG10 Severe asthma in adults: systematic assessment and biological treatment
Session:
PG10 Severe asthma in adults: systematic assessment and biological treatment
Session type:
Postgraduate Course
Number:
16
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Backer (Copenhagen, Denmark). Making clinical sense of the explosion in biologics - which drug for which patient and why?. International Congress 2019 – PG10 Severe asthma in adults: systematic assessment and biological treatment
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Getting approval for new therapeutic medical devices versus drugs: are the differences justified?
Source: Eur Respir Rev 2016; 25: 223-226
Year: 2016
Telemonitoring in clinical practice: a way forward?
Source: Annual Congress 2013 –Primary Care Programme "Asthma management in clinical practice"
Year: 2013
Your new BT service - Making it happen
Source: International Congress 2014 – Bronchial thermoplasty: clinically proven long-term safety and efficacy in severe asthma
Year: 2014
Introducing a new formulation of pirfenidone to reduce tablet burden for the IPF patient: Is it tolerable? Is it easy to take? What do our patients think?
Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments
Year: 2018
"Don’t get me wrong, I think case finding is okay" Exploring healthcare professionals’ perspectives on target case-finding for COPD
Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care
Year: 2016
ACCP1 - Is telemedicine in your future?
Source: Annual Congress 2008 - MP17 - ACCP: Is telemedicine in your future?
Year: 2008
Tuberculosis elimination, patients' lives and rational use of new drugs: revisited
Source: Eur Respir J 2016; 47: 664-667
Year: 2016
Anti-IgE: changing lives in clinical practice?
Source: Eur Respir Rev 2007; 16: 59-60
Year: 2007
Is our approach to basic research right? Pitfalls and successes: what is the way forward?
Source: ERS Research Seminar 2016
Year: 2016
Monitoring at home - telemedicine, how and why?
Source: Annual Congress 2004 - PG21 - Home mechanical ventilation in COPD patients
Year: 2004
Cleaning agents and asthma: what does the evidence currently tell us about diagnosis and management of these cases?
Source: International Congress 2018 – Cleaning agent exposures: are they really harmful to lung health?
Year: 2018
What do we need from our patients? - the clinician's point of view
Source: International Congress 2014 – PG17 Lung cancer: the issue with the tissue
Year: 2014
The sustainability agenda and inhaled therapy: what do patients want?
Source: Virtual Congress 2021 – Asthma inhalers: new devices and adherence
Year: 2021
What's new in the management of CAP?
Source: Annual Congress 2012 - New guidelines in respiratory infections
Year: 2012
The paradoxes of asthma management: time for a new approach?
Source: Eur Respir J, 50 (3) 1701103; 10.1183/13993003.01103-2017
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept